FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789324730> ?p ?o ?g. }

• W2789324730 endingPage "15" @default.
• W2789324730 startingPage "9" @default.
• W2789324730 abstract "Objective This study aimed to evaluate the long-term effectiveness and safety of the first anti–tumor necrosis factor α therapy (TNFi) and to identify the associated factors of drug discontinuation in patients with spondyloarthritis. Methods This was a medical records review study. Patients with spondyloarthritis who were prescribed the first TNFi between December 2009 and October 2014 in the Rheumatic Disease Prior Authorization registry were enrolled. Baseline clinical data were retrieved. The Cox proportional hazards model was used to identify factors associated with discontinuation of drugs. Results Among 138 patients, 97 had ankylosing spondylitis (AS), and 41 had psoriatic arthritis (PsA). The effectiveness of TNFi in AS and PsA was 55% to 59% at 4 months and 75% to 96% at 3 years, as measured by a 50% decrease in the Bath Ankylosing Spondylitis Disease Activity Index from baseline. For PsA with peripheral arthritis, improvement of the joint count by 50% was observed in 61.8% of patients at 4 months and 100% at 3 years. Survival from TNFi was 63% for AS and 56% for PsA at 3 years. For AS, the factors associated with good response leading to discontinuation of TNFi were baseline patient global assessment 3 to 6/10 (hazard ratio [HR], 6.3) and the use of leflunomide (HR, 6.0) and infliximab (HR, 4.8). A good response (38.5%) was the most common cause of discontinuation of the first TNFi, followed by toxicity (28.2%), nonadherence (20.5%), and lack of effectiveness (12.8%). Conclusions Ankylosing spondylitis and PsA responded well to TNFi during the 3-year follow-up. The retention rate was approximately 60% for AS and PsA. A good response to the first TNFi was the most common reason for discontinuation." @default.
• W2789324730 created "2018-03-29" @default.
• W2789324730 creator A5014870649 @default.
• W2789324730 creator A5016080278 @default.
• W2789324730 creator A5020515015 @default.
• W2789324730 creator A5030712947 @default.
• W2789324730 creator A5033859055 @default.
• W2789324730 creator A5041006807 @default.
• W2789324730 creator A5063503339 @default.
• W2789324730 creator A5073062098 @default.
• W2789324730 date "2019-01-01" @default.
• W2789324730 modified "2023-09-29" @default.
• W2789324730 title "Effectiveness and Drug Survival of Anti–Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis" @default.
• W2789324730 cites W1558329586 @default.
• W2789324730 cites W1871608943 @default.
• W2789324730 cites W1966756689 @default.
• W2789324730 cites W1975137544 @default.
• W2789324730 cites W1979060964 @default.
• W2789324730 cites W1988532712 @default.
• W2789324730 cites W1990305566 @default.
• W2789324730 cites W2037976962 @default.
• W2789324730 cites W2045317929 @default.
• W2789324730 cites W2073005986 @default.
• W2789324730 cites W2081388746 @default.
• W2789324730 cites W2092773063 @default.
• W2789324730 cites W2096703320 @default.
• W2789324730 cites W2131579537 @default.
• W2789324730 cites W2132229723 @default.
• W2789324730 cites W2132960802 @default.
• W2789324730 cites W2133696182 @default.
• W2789324730 cites W2134009713 @default.
• W2789324730 cites W2145778588 @default.
• W2789324730 cites W2149168537 @default.
• W2789324730 cites W2159212884 @default.
• W2789324730 cites W2159813676 @default.
• W2789324730 cites W2163741803 @default.
• W2789324730 cites W2167795826 @default.
• W2789324730 cites W2170446962 @default.
• W2789324730 cites W2177257388 @default.
• W2789324730 cites W2215504656 @default.
• W2789324730 cites W2223868808 @default.
• W2789324730 cites W2559582708 @default.
• W2789324730 cites W2572897530 @default.
• W2789324730 cites W4211046919 @default.
• W2789324730 doi "https://doi.org/10.1097/rhu.0000000000000741" @default.
• W2789324730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29517554" @default.
• W2789324730 hasPublicationYear "2019" @default.
• W2789324730 type Work @default.
• W2789324730 sameAs 2789324730 @default.
• W2789324730 citedByCount "3" @default.
• W2789324730 countsByYear W27893247302019 @default.
• W2789324730 countsByYear W27893247302022 @default.
• W2789324730 crossrefType "journal-article" @default.
• W2789324730 hasAuthorship W2789324730A5014870649 @default.
• W2789324730 hasAuthorship W2789324730A5016080278 @default.
• W2789324730 hasAuthorship W2789324730A5020515015 @default.
• W2789324730 hasAuthorship W2789324730A5030712947 @default.
• W2789324730 hasAuthorship W2789324730A5033859055 @default.
• W2789324730 hasAuthorship W2789324730A5041006807 @default.
• W2789324730 hasAuthorship W2789324730A5063503339 @default.
• W2789324730 hasAuthorship W2789324730A5073062098 @default.
• W2789324730 hasConcept C126322002 @default.
• W2789324730 hasConcept C17991360 @default.
• W2789324730 hasConcept C207103383 @default.
• W2789324730 hasConcept C2776260265 @default.
• W2789324730 hasConcept C2777138892 @default.
• W2789324730 hasConcept C2777226972 @default.
• W2789324730 hasConcept C2777402515 @default.
• W2789324730 hasConcept C2777575956 @default.
• W2789324730 hasConcept C2778715236 @default.
• W2789324730 hasConcept C44249647 @default.
• W2789324730 hasConcept C50382708 @default.
• W2789324730 hasConcept C71924100 @default.
• W2789324730 hasConceptScore W2789324730C126322002 @default.
• W2789324730 hasConceptScore W2789324730C17991360 @default.
• W2789324730 hasConceptScore W2789324730C207103383 @default.
• W2789324730 hasConceptScore W2789324730C2776260265 @default.
• W2789324730 hasConceptScore W2789324730C2777138892 @default.
• W2789324730 hasConceptScore W2789324730C2777226972 @default.
• W2789324730 hasConceptScore W2789324730C2777402515 @default.
• W2789324730 hasConceptScore W2789324730C2777575956 @default.
• W2789324730 hasConceptScore W2789324730C2778715236 @default.
• W2789324730 hasConceptScore W2789324730C44249647 @default.
• W2789324730 hasConceptScore W2789324730C50382708 @default.
• W2789324730 hasConceptScore W2789324730C71924100 @default.
• W2789324730 hasIssue "1" @default.
• W2789324730 hasLocation W27893247301 @default.
• W2789324730 hasLocation W27893247302 @default.
• W2789324730 hasOpenAccess W2789324730 @default.
• W2789324730 hasPrimaryLocation W27893247301 @default.
• W2789324730 hasRelatedWork W1516746560 @default.
• W2789324730 hasRelatedWork W2015993259 @default.
• W2789324730 hasRelatedWork W2018484452 @default.
• W2789324730 hasRelatedWork W2081194146 @default.
• W2789324730 hasRelatedWork W2087248190 @default.
• W2789324730 hasRelatedWork W2157626067 @default.
• W2789324730 hasRelatedWork W2327257788 @default.
• W2789324730 hasRelatedWork W2946910872 @default.

• next